Metabolon Raises $5.3M in Private Financing | GenomeWeb

NEW YORK (GenomeWeb News) – Metabolon has raised $5.3 million from a Series C funding round, the firm said today.

The Research Triangle Park, NC-based metabolomics services company said that it anticipates raising a total of $11 million in the round. It closed the first $5.3 million last week, and it expects to receive the rest of the funding within the next 60 to 90 days.

Metabolon CEO John Ryals said that the funding will enable the firm to launch its diagnostics business with products for prostate cancer and insulin resistance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.